A144510 Stock Overview
Develops cell therapy products. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
GC Cell Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩24,650.00 |
| 52 Week High | ₩48,800.00 |
| 52 Week Low | ₩21,250.00 |
| Beta | 0.93 |
| 1 Month Change | -10.85% |
| 3 Month Change | -24.27% |
| 1 Year Change | -26.75% |
| 3 Year Change | -76.48% |
| 5 Year Change | -30.76% |
| Change since IPO | -48.75% |
Recent News & Updates
The Market Doesn't Like What It Sees From GC Cell Corporation's (KOSDAQ:144510) Revenues Yet As Shares Tumble 27%
Dec 01
Revenues Working Against GC Cell Corporation's (KOSDAQ:144510) Share Price
Oct 14Is GC Cell (KOSDAQ:144510) A Risky Investment?
Sep 08Recent updates
The Market Doesn't Like What It Sees From GC Cell Corporation's (KOSDAQ:144510) Revenues Yet As Shares Tumble 27%
Dec 01Revenues Working Against GC Cell Corporation's (KOSDAQ:144510) Share Price
Oct 14Is GC Cell (KOSDAQ:144510) A Risky Investment?
Sep 08We Think Green Cross Lab Cell's (KOSDAQ:144510) Robust Earnings Are Conservative
Mar 19We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt
Feb 22Can Green Cross Lab Cell Corporation (KOSDAQ:144510) Improve Its Returns?
Jan 18
Can You Imagine How Jubilant Green Cross Lab Cell's (KOSDAQ:144510) Shareholders Feel About Its 139% Share Price Gain?
Dec 14Shareholder Returns
| A144510 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | 5.1% | 7.0% | 3.1% |
| 1Y | -26.7% | 29.7% | -5.3% |
Return vs Industry: A144510 underperformed the KR Biotechs industry which returned 20.7% over the past year.
Return vs Market: A144510 underperformed the KR Market which returned -5.3% over the past year.
Price Volatility
| A144510 volatility | |
|---|---|
| A144510 Average Weekly Movement | 7.5% |
| Biotechs Industry Average Movement | 8.9% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.6% |
| 10% least volatile stocks in KR Market | 3.2% |
Stable Share Price: A144510 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A144510's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 752 | James Park | www.gccell.com |
GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. Its main product is Immuncell-LC.
GC Cell Corporation Fundamentals Summary
| A144510 fundamental statistics | |
|---|---|
| Market cap | ₩370.42b |
| Earnings (TTM) | -₩3.39b |
| Revenue (TTM) | ₩184.36b |
2.0x
P/S Ratio-109.3x
P/E RatioIs A144510 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A144510 income statement (TTM) | |
|---|---|
| Revenue | ₩184.36b |
| Cost of Revenue | ₩137.39b |
| Gross Profit | ₩46.96b |
| Other Expenses | ₩50.35b |
| Earnings | -₩3.39b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -225.49 |
| Gross Margin | 25.48% |
| Net Profit Margin | -1.84% |
| Debt/Equity Ratio | 11.9% |
How did A144510 perform over the long term?
See historical performance and comparison